TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314309. A total of 37 filers reported holding TITAN PHARMACEUTICALS INC DE in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $3,000 | – | 2,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
THOMPSON DAVIS & CO., INC. | 16,184 | $95,000 | 0.17% |
Acrospire Investment Management LLC | 30,847 | $181,000 | 0.12% |
Spark Investment Management LLC | 24,000 | $141,000 | 0.01% |
ACCURATE INVESTMENT SOLUTIONS, INC. | 2,000 | $12,000 | 0.01% |
Blume Capital Management, Inc. | 2,546 | $15,000 | 0.01% |
BLUESTEIN R H & CO LLC | 20,000 | $118,000 | 0.01% |
Virtu KCG Holdings LLC | 42,562 | $250,000 | 0.01% |
ARCADIA INVESTMENT MANAGEMENT CORP/MI | 1,819 | $11,000 | 0.00% |
Integrated Wealth Management | 910 | $5,000 | 0.00% |
Krilogy Financial LLC | 800 | $5,000 | 0.00% |